Prospective evaluation of radical prostatectomy without prior biopsy based on PSA or DRE, mpMRI and PSMA-PET

Prospective evaluation of radical prostatectomy without prior biopsy based on PSA or DRE, mpMRI and PSMA-PET

Bibliographic Details
Main Authors:	C. Stief, M. Chaloupka
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168324002775

Similar Items

The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy
by: Łukasz Nyk, et al.
Published: (2021-05-01)

Targeted prostate biopsy: 68Ga-PSMA PET/CT vs. mpMRI in the diagnosis of prostate cancer
by: Pietro Pepe, et al.
Published: (2022-09-01)

Indeterminate mpMRI lesions: Evaluating the optimal PSA density threshold for prostate biopsy
by: D.T. Reddy, et al.
Published: (2020-07-01)

Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
by: Miriam Campistol, et al.
Published: (2022-05-01)

Adverse Pathology after Radical Prostatectomy of Patients Eligible for Active Surveillance—A Summary 7 Years after Introducing mpMRI-Guided Biopsy in a Real-World Setting
by: Benedikt Ebner, et al.
Published: (2023-02-01)

The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study
by: Abraham M. Getaneh, et al.
Published: (2021-01-01)

Targeted 11C–choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy
by: Massimo Lazzeri, et al.
Published: (2017-11-01)

Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical Prostatectomy
by: Eoin Dinneen, et al.
Published: (2022-04-01)

Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer
by: Samuel Carbunaru, et al.
Published: (2021-11-01)

Which men should undergo non-targeted systematic sampling in an mpMRI-targeted pathway – an analysis from 1,719 pre-biopsy mpMRI cases?
by: M.J. Connor, et al.
Published: (2020-07-01)

Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge
by: Luigia Vetrone, et al.
Published: (2023-02-01)

Intraoperative 3D-US-mpMRI Elastic Fusion Imaging-Guided Robotic Radical Prostatectomy: A Pilot Study
by: Marco Oderda, et al.
Published: (2022-12-01)

Diagnostic performance of micro-ultrasound prostate biopsies in patients undergoing mpMRI-fusion biopsies
by: D. Maffei, et al.
Published: (2020-07-01)

Developing a predictive model for clinically significant prostate cancer by combining age, PSA density, and mpMRI
by: Zengni Ma, et al.
Published: (2023-03-01)

Correlation between mpMRI-detected lesions and definite neoplastic foci at radical prostatectomy: Level of agreement in terms of size and proximity to the capsule
by: E. Morini, et al.
Published: (2020-01-01)

Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer
by: Qing Zhang, et al.
Published: (2017-11-01)

Incidence and Predicting Factors of Histopathological Features at Robot-Assisted Radical Prostatectomy in the mpMRI Era: Results of a Single Tertiary Referral Center
by: Ernesto Di Mauro, et al.
Published: (2023-03-01)

Nomogram including maximum core length at biopsy and index lesion size at mpMRI best predicts the extra-capsular extension of prostate cancer at whole-mount sections of radical prostatectomies
by: F. Sanguedolce, et al.
Published: (2020-07-01)

Analysis of the cause of missed diagnosis in mpMRI/TRUS fusion-guided targeted prostate biopsy
by: Fan Zhang, et al.
Published: (2022-05-01)

Prostate mpMRI and MRI-Targeted Biopsy: State-of-the-art Protocol + PI-RADS v2.1
by: Pieter De Visschere, et al.
Published: (2019-11-01)

<sup>68</sup>Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
by: Finn Edler von Eyben, et al.
Published: (2021-03-01)

Which is the value of a negative mpMRI in ruling out adverse pathological outcomes at radical prostatectomy?: A retrospective analysis on 212 prostatic lobes
by: S. Ciarlariello, et al.
Published: (2020-01-01)

Mischievous malakoplakia: A potential pitfall of mpMRI of the prostate?
by: Michael E. Rezaee, et al.
Published: (2020-09-01)

False Positive Findings of [18F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels
by: Marina Orevi, et al.
Published: (2022-06-01)

Changes of Radiation Treatment Concept Based on 68Ga-PSMA-11-PET/CT in Early PSA-Recurrences After Radical Prostatectomy
by: Dirk Bottke, et al.
Published: (2021-06-01)

Prostate “Mapeo” for cancer diagnosis: The Madrid protocol. Transperineal prostate biopsies combining Micro-ultrasound and mpMRI fusion biopsy.
by: M.E. Rodríguez Socarrás, et al.
Published: (2020-01-01)

Prostate mapping for cancer diagnosis: The Madrid protocol. Transperineal prostate biopsies combining micro-ultrasound and mpMRI fusion biopsy
by: M.E. Rodríguez Socarrás, et al.
Published: (2020-07-01)

The role of multiparametric MRI and 68-Ga-PSMA PET/MRI in determining the location of index tumor in radical prostatectomy specimen
by: U. Coşar, et al.
Published: (2020-07-01)

Clash of the calculators: External validation of prostate cancer risk calculators in men undergoing mpMRI and transperineal biopsy
by: G. Wei, et al.
Published: (2021-05-01)

Added value of risk calculators to mpMRI in the diagnosis of prostate cancer
by: J.R. Gonçalves Correia, et al.
Published: (2020-07-01)

Which prostate cancers are overlooked by mpMRI? An analysis from PROMIS
by: J. Norris, et al.
Published: (2020-07-01)

Micro-ultrasound guided prostate biopsies for clinically significant prostate cancer diagnosis in a cohort of biopsy-naive patients with mpMRI
by: D. Maffei, et al.
Published: (2020-11-01)

Applications of Artificial Intelligence to Prostate Multiparametric MRI (mpMRI): Current and Emerging Trends
by: Michelle D. Bardis, et al.
Published: (2020-05-01)

bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study
by: Yongsheng Pan, et al.
Published: (2023-01-01)

Detection of clinically significant prostate cancer with PI-RADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions
by: Antonio C. Westphalen, et al.

The combined value of mpUS and mpMRI-TRUS fusion for the diagnosis of clinically significant prostate cancer
by: Xin Zhang, et al.
Published: (2022-10-01)

Age and Gleason score upgrading between prostate biopsy and radical prostatectomy. Is this still true in the mp-MRI era?
by: F. Pellegrino, et al.
Published: (2020-10-01)

Development and validation of a predictive model based on clinical and MpMRI findings to reduce additional systematic prostate biopsy
by: Xueqing Cheng, et al.
Published: (2024-01-01)

Assessing the value of mpMRI PIRADS lesions in the transitional zone: Analysis of a single center repeat biopsy cohort
by: L. Sarchi, et al.
Published: (2020-01-01)

68Ga-PSMA PET/CT and mpMRI for primary lymph node staging of intermediate to high-risk prostate cancer: a systematic review and meta-analysis of diagnostic test accuracy
by: Yip, KCJ, et al.
Published: (2021)